These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23590830)

  • 41. [Local recurrence after radical cystectomy for cancer of the bladder].
    Herranz Amo F; Verdú Tartajo F; Díez Cordero JM; Bueno Chomón G; Leal Hernández F; Bielsa Carrillo A
    Actas Urol Esp; 1998 May; 22(5):417-22. PubMed ID: 9675922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Similar treatment outcomes for radical cystectomy and radical radiotherapy in invasive bladder cancer treated at a United Kingdom specialist treatment center.
    Kotwal S; Choudhury A; Johnston C; Paul AB; Whelan P; Kiltie AE
    Int J Radiat Oncol Biol Phys; 2008 Feb; 70(2):456-63. PubMed ID: 17904301
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Super extended versus extended pelvic lymph node dissection in patients undergoing radical cystectomy for bladder cancer: a comparative study.
    Zehnder P; Studer UE; Skinner EC; Dorin RP; Cai J; Roth B; Miranda G; Birkhäuser F; Stein J; Burkhard FC; Daneshmand S; Thalmann GN; Gill IS; Skinner DG
    J Urol; 2011 Oct; 186(4):1261-8. PubMed ID: 21849183
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.
    Herrmann E; Stöter E; van Ophoven A; Bierer S; Bolenz C; Hertle L; Wülfing C
    Int J Urol; 2008 Jul; 15(7):607-11. PubMed ID: 18462352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Upper urinary tract recurrence after radical cystectomy for bladder cancer: incidence and risk factors.
    Takayanagi A; Masumori N; Takahashi A; Takagi Y; Tsukamoto T
    Int J Urol; 2012 Mar; 19(3):229-33. PubMed ID: 22121922
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Predicting individual outcomes after radical cystectomy: an external validation of current nomograms.
    Zaak D; Burger M; Otto W; Bastian PJ; Denzinger S; Stief CG; Buchner H; Hartmann A; Wieland WF; Shariat SF; Fritsche HM
    BJU Int; 2010 Aug; 106(3):342-8. PubMed ID: 20002664
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Usefulness of the Memorial Sloan Kettering Cancer Center nomogram in the prognosis of patients treated with radical cystectomy for invasive bladder cancer.
    Molina Escudero R; Herranz Amo F; Monzo Gardiner J; Paez Borda A; Hernandez Fernandez C
    Arch Esp Urol; 2013 Nov; 66(9):859-64. PubMed ID: 24231296
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Survival after treatment for carcinoma invading bladder muscle: a Dutch population-based study on the impact of hospital volume.
    Goossens-Laan CA; Visser O; Hulshof MC; Wouters MW; Bosch JL; Coebergh JW; Kil PJ
    BJU Int; 2012 Jul; 110(2):226-32. PubMed ID: 22044615
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Radical cystectomy for urothelial carcinoma of the bladder: an analysis of perioperative and survival outcome.
    Manoharan M; Ayyathurai R; Soloway MS
    BJU Int; 2009 Nov; 104(9):1227-32. PubMed ID: 19519764
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The effect of cystectomy, and perioperative methotrexate, vinblastine, doxorubicin and cisplatin chemotherapy on the risk and pattern of relapse in patients with muscle invasive bladder cancer.
    Ennis RD; Petrylak DP; Singh P; Bagiella E; O'Toole KM; Benson MC; Olsson CA
    J Urol; 2000 May; 163(5):1413-8. PubMed ID: 10751847
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Lymphovascular invasion, ureteral reimplantation and prior history of urothelial carcinoma are associated with poor prognosis after partial cystectomy for muscle-invasive bladder cancer with negative pelvic lymph nodes.
    Ma B; Li H; Zhang C; Yang K; Qiao B; Zhang Z; Xu Y
    Eur J Surg Oncol; 2013 Oct; 39(10):1150-6. PubMed ID: 23721764
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Benefit in regionalisation of care for patients treated with radical cystectomy: a nationwide inpatient sample analysis.
    Ravi P; Bianchi M; Hansen J; Trinh QD; Tian Z; Meskawi M; Abdollah F; Briganti A; Shariat SF; Perrotte P; Montorsi F; Karakiewicz PI; Sun M
    BJU Int; 2014 May; 113(5):733-40. PubMed ID: 24007240
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Extended versus limited lymph node dissection in radical cystectomy: impact on recurrence pattern and survival.
    Jensen JB; Ulhøi BP; Jensen KM
    Int J Urol; 2012 Jan; 19(1):39-47. PubMed ID: 22050425
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Lymphovascular invasion and the presence of more than three tumors are associated with poor outcomes of muscle-invasive bladder cancer after bladder-conserving therapies.
    Zhang M; Tao R; Zhang C; Shen Z
    Urology; 2010 Oct; 76(4):902-7. PubMed ID: 20709377
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Presentation, location and overall survival of pelvic recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
    Dhar NB; Jones JS; Reuther AM; Dreicer R; Campbell SC; Sanii K; Klein EA
    BJU Int; 2008 Apr; 101(8):969-72. PubMed ID: 18005201
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Stage pT0 at radical cystectomy confers improved survival: an international study of 4,430 patients.
    Tilki D; Svatek RS; Novara G; Seitz M; Godoy G; Karakiewicz PI; Kassouf W; Fradet Y; Fritsche HM; Sonpavde G; Izawa JI; Ficarra V; Lerner SP; Schoenberg M; Stief CG; Dinney CP; Skinner E; Lotan Y; Sagalowsky AI; Reich O; Shariat SF
    J Urol; 2010 Sep; 184(3):888-94. PubMed ID: 20643448
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oncological outcome after radical cystectomy and orthotopic bladder substitution in women.
    Ali-El-Dein B
    Eur J Surg Oncol; 2009 Mar; 35(3):320-5. PubMed ID: 18434072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Surgical factors influence bladder cancer outcomes: a cooperative group report.
    Herr HW; Faulkner JR; Grossman HB; Natale RB; deVere White R; Sarosdy MF; Crawford ED
    J Clin Oncol; 2004 Jul; 22(14):2781-9. PubMed ID: 15199091
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A precystectomy decision model to predict pathological upstaging and oncological outcomes in clinical stage T2 bladder cancer.
    Mitra AP; Skinner EC; Miranda G; Daneshmand S
    BJU Int; 2013 Feb; 111(2):240-8. PubMed ID: 22928881
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Critical evaluation of the American Joint Committee on Cancer TNM nodal staging system in patients with lymph node-positive disease after radical cystectomy.
    Bruins HM; Dorin RP; Rubino B; Miranda G; Cai J; Daneshmand S; Skinner EC
    Eur Urol; 2012 Oct; 62(4):671-6. PubMed ID: 22575915
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.